Literature DB >> 18032773

Genomewide study of multiple sclerosis.

Sreeram V Ramagopalan, Carl Anderson, A Dessa Sadovnick, George C Ebers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18032773     DOI： 10.1056/NEJMc072836

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  24 in total

1.  Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Authors:  Marie-Claude Babron; Hervé Perdry; Adam E Handel; Sreeram V Ramagopalan; Vincent Damotte; Bertrand Fontaine; Bertram Müller-Myhsok; George C Ebers; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

2.  IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients.

Authors:  Nicolas Couturier; Pierre-Antoine Gourraud; Isabelle Cournu-Rebeix; Claire Gout; Florence Bucciarelli; Gilles Edan; Marie-Claude Babron; Françoise Clerget-Darpoux; Michel Clanet; Bertrand Fontaine; David Brassat
Journal:  Eur J Hum Genet       Date:  2009-01-21       Impact factor: 4.246

3.  Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.

Authors:  Claire Dandine-Roulland; Hervé Perdry
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

Review 4.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

5.  Association between the IL7R T244I polymorphism and multiple sclerosis risk: a meta analysis.

Authors:  Song Wu; Qian Liu; Ji-Min Zhu; Ming-Rui Wang; Jing Li; Mei-Guo Sun
Journal:  Neurol Sci       Date:  2016-05-17       Impact factor: 3.307

Review 6.  The immunogenetics of multiple sclerosis: A comprehensive review.

Authors:  Jill A Hollenbach; Jorge R Oksenberg
Journal:  J Autoimmun       Date:  2015-07-02       Impact factor: 7.094

7.  The role of the CD58 locus in multiple sclerosis.

Authors:  Philip L De Jager; Clare Baecher-Allan; Lisa M Maier; Ariel T Arthur; Linda Ottoboni; Lisa Barcellos; Jacob L McCauley; Stephen Sawcer; An Goris; Janna Saarela; Roman Yelensky; Alkes Price; Virpi Leppa; Nick Patterson; Paul I W de Bakker; Dong Tran; Cristin Aubin; Susan Pobywajlo; Elizabeth Rossin; Xinli Hu; Charles W Ashley; Edwin Choy; John D Rioux; Margaret A Pericak-Vance; Adrian Ivinson; David R Booth; Graeme J Stewart; Aarno Palotie; Leena Peltonen; Bénédicte Dubois; Jonathan L Haines; Howard L Weiner; Alastair Compston; Stephen L Hauser; Mark J Daly; David Reich; Jorge R Oksenberg; David A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

9.  IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.

Authors:  Lisa M Maier; Christopher E Lowe; Jason Cooper; Kate Downes; David E Anderson; Christopher Severson; Pamela M Clark; Brian Healy; Neil Walker; Cristin Aubin; Jorge R Oksenberg; Stephen L Hauser; Alistair Compston; Stephen Sawcer; Philip L De Jager; Linda S Wicker; John A Todd; David A Hafler
Journal:  PLoS Genet       Date:  2009-01-02       Impact factor: 5.917

10.  The genetic basis of multiple sclerosis: a model for MS susceptibility.

Authors:  Douglas S Goodin
Journal:  BMC Neurol       Date:  2010-10-28       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.